NCT05671822 2026-02-12
Ph1b/2 Study of the Safety and Efficacy of SHR-A1811 Combinations in Advanced HER2 Expression Gastric Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 2 Recruiting
Clinical Trials
7 trialsNCT07175220 2025-11-18
Phase II Clinical Study of SHR2554 Tablets Combined With Other Anti-tumor Treatments in Non-small Cell Lung Cancer Subjects
Jiangsu HengRui Medicine Co., Ltd.
Phase 2 Recruiting
NCT07102901 2025-09-10
Safety and Efficacy of SHR2554 Combined With Other Antitumor Therapies in Gastric or Gastro-oesophageal Junction Adenocarcinoma
Jiangsu HengRui Medicine Co., Ltd.
Phase 2 Recruiting
NCT04699968 2023-06-07
A Trial of SHR-1701 With or Without Famitinib in Patients With Advanced or Metastatic NSCLC
Jiangsu HengRui Medicine Co., Ltd.
Phase 2 Withdrawn
NCT04580498 2023-05-19
A Trial of SHR-1701 With or Without Chemotherapy in Patients With Stage III NSCLC
Jiangsu HengRui Medicine Co., Ltd.
Phase 2 Unknown
NCT04650633 2021-10-29
SHR-1701 in Patients With Recurrent/Metastatic Scchn
Jiangsu HengRui Medicine Co., Ltd.
Phase 2 Unknown
NCT04884009 2021-05-12
A Trial of SHR-1701 in Combination With and Without Famitinib Malate in Patients With Extensive Stage Small Cell Lung Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 2 Unknown